AzTrials
AzTrials

Hearing LossNCT04021641

The Construction and Validation of CanSRINT

An observational study of Hearing Loss, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An open-set sentence speech recognition in noise test in Cantonese Chinese, which is applicable on children and adults with hearing impairment, is proposed to be developed in this project. Read more about this study

Who is it for?
Ages 6 years and olderHealthy volunteers can take part
Conditions the study is for
Hearing Loss
What is being tested?
Speech recognition in noise
How many people
113 participants
Where
1 siteHong Kong
Study dates
29 Jun 2019to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Participants with typical hearing, from each of the 5 age groups from their 6 years of age to adulthood, will be recruited to contribute to the normative data of the proposed test. One hundred participants with various degree of hearing impairment will be recruited for the validation of the proposed new test.

Who may be able to join

  • Native in Catonese

Who cannot join

  • Have overall cognitive and developmental impairment

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • The Chinese University of Hong Kong

    Hong Kong, 0000

Other trials in Hong Kong

About this study

Official title: The Construction and Validation of Cantonese Sentence Recognition in Noise Test

An open-set sentence speech recognition in noise test in Cantonese Chinese, which is applicable on children and adults with hearing impairment, is proposed to be developed in this project.

Read the detailed description

INTRODUCTION: Speech recognition in noise is an important aspect of human communication. One's speech recognition ability in noise is inevitably affected by any hearing impairment, and may only be quantified with specific language at an appropriate difficulty.

There is a niche among clinically available test materials between word recognition and 10- syllable sentence recognition in noise in Cantonese Chinese. Ten-syllable sentence items are commented to be too challenging to young children and elderly population. An assessment tool for pediatric patients, and the whole spectrum of patients with significant hearing impairment, compromised language or cognitive abilities, is deemed necessary. Both the research and clinical audiology communities need a valid and reliable outcome measurement tool for sentence recognition abilities in noise of the specific population.

An open-set sentence speech recognition in noise test in Cantonese Chinese, which is applicable on children and adults with hearing impairment, is proposed to be developed in this project to bridge the gap.

METHODS: Thirty three participants with typical hearing, from each of the 5 age groups from their 6 years of age to adulthood, will be recruited to contribute to the normative data of the proposed test. One hundred participants with various degree of hearing impairment will be recruited for the validation of the proposed new test as well.

A sentence pool of at least 150 sentence items will be constructed based on the basic sentence syntax in Cantonese Chinese. Each sentence item will be 7 syllables in length on average. The words used in the sentences will be words frequently used in daily life by both persons with typical hearing and hearing impairment. A 4-talker babble in Cantonese Chinese will be generated as the competing noise in this proposed new test.

OUTCOMES: By Rasch modelling, sentence items with high probability of consistently and accurately estimating sentence recognition ability in noise across different participants will be selected and distributed to a few parallel lists.

Rater and test-retest reliability of the test items and lists will be established.

Content-related and construct-related evidence of validity of lists will also be supported by psychometric analyses as well as expert consultation.

APPLICATION: A valid and reliable assessment tool, of sentence recognition ability in noise in Cantonese, applicable to persons with hearing sensitivity ranging from profound impairment to typical, in both the research and clinical audiology fields, will be constructed.

Conditions
Hearing Loss
Being tested
Speech recognition in noise
Medical subject headings
Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Speech recognition in noiseDiagnostic test

    Measurement of speech recognition performance in noise

Study groups in NCT04021641
Study groupRoleWhat they receive
Participants with Typical HearingFrom 5 age groups from their 6 years of age to adulthood
Receives: Diagnostic Test: Speech recognition in noise
Participants with Hearing ImpairmentParticipants with various degree of hearing impairment
Receives: Diagnostic Test: Speech recognition in noise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Person Ability of Participants in Sentence Recognition in Noise

    In accordance with Item Response Theory, the ability of individual participants in sentence recognition in noise, measured by the proposed new test, is generated through Rasch modelling or other relevant models.

    Measured: up to 1 month

  2. Item Difficulty of Test Items in Sentence Recognition in Noise

    In accordance with Item Response Theory, the difficulty of individual proposed test items in sentence recognition in noise, contributed by all participants, is generated through Rasch modelling or other relevant models.

    Measured: up to 3 years

Secondary outcomes (5)
  1. Internal Consistency of Test Items

    Cronbach's alpha or other relevant measurements will be used to estimate the consistency of the items on measuring the same dimension.

    Measured: up to 3 years

  2. Rater Reliability of Test Items

    A portion of the test sessions will be scored twice by more than one raters. The intra-class correlation (ICC) or other relevant measurements will be employed to estimate rater reliability.

    Measured: up to 1 month

  3. Test-Retest Reliability of Test Items

    A portion of participants will be tested twice. Pearson's coefficient of correlation or other relevant measurements will be computed to measure the correlation between the first and the second test results.

    Measured: up to 1 month

  4. Content-related Evidence of Validity of Test Items

    Construction of sentence test items with elements from various relevant language corpus, based on the basic sentence syntax in Cantonese Chinese, and evaluated with reference to expert opinions, will be regarded as content-related evidence of the test item validity.

    Measured: up to 3 years

  5. Construct-related Evidence of Validity of Test Items

    Unidimensionality and local independence, or other relevant measurements, in accordance with Item Response Theory, will be regarded as construct-related evidence of the test item validity.

    Measured: up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2019
  2. Study start29 Jun 2019
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
113 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04021641
Sponsor's protocol ID
ChineseUHK_CREC2018.639
Status last verified
Sep 2023
First submitted
11 Jul 2019
Last updated
21 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Hearing Loss, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Person Ability of Participants in Sentence Recognition in Noise (time frame: up to 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in